Recombinant multi-species NAPRT1/NAPRT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NAPRT1/NAPRT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Nicotinic acid (NA; niacin) is converted by nicotinic acid phosphoribosyltransferase (NAPRT; EC 2.4.2.11) to NA mononucleotide (NaMN), which is then converted to NA adenine dinucleotide (NaAD), and finally to nicotinamide adenine dinucleotide (NAD), which serves as a coenzyme in cellular redox reactions and is an essential component of a variety of processes in cellular metabolism including response to stress (Hara et al., 2007).[supplied by OMIM, Mar 2008]
The Alternative Names of target: 9130210N20Rik,FHA-HIT-interacting protein,NAPRT,NAPRT1,NAPRTase,Naprt,Naprt1,Nicotinate phosphoribosyltransferase,Nicotinate phosphoribosyltransferase domain-containing protein 1,PP3856

Target products collectionGo to NAPRT1/NAPRT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13667-Ag-1/ GM-Tg-hg-IP13667-Ag-2 Human NAPRT1/NAPRT protein Human
GM-Tg-rg-IP13667-Ag-1/ GM-Tg-rg-IP13667-Ag-2 Rat NAPRT1/NAPRT protein Rat
GM-Tg-mg-IP13667-Ag-1/ GM-Tg-mg-IP13667-Ag-2 Mouse NAPRT1/NAPRT protein Mouse
GM-Tg-cynog-IP13667-Ag-1/ GM-Tg-cynog-IP13667-Ag-2 Cynomolgus/Rhesus macaque NAPRT1/NAPRT protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13667-Ag-1/ GM-Tg-felg-IP13667-Ag-2 Feline NAPRT1/NAPRT protein Feline
GM-Tg-cang-IP13667-Ag-1/ GM-Tg-cang-IP13667-Ag-2 Canine NAPRT1/NAPRT protein Canine
GM-Tg-bovg-IP13667-Ag-1/ GM-Tg-bovg-IP13667-Ag-2 Bovine NAPRT1/NAPRT protein Bovine
GM-Tg-equg-IP13667-Ag-1/ GM-Tg-equg-IP13667-Ag-2 Equine NAPRT1/NAPRT protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13667-Ag-1/ GM-Tg-hg-IP13667-Ag-2; GM-Tg-rg-IP13667-Ag-1/ GM-Tg-rg-IP13667-Ag-2;
GM-Tg-mg-IP13667-Ag-1/ GM-Tg-mg-IP13667-Ag-2; GM-Tg-cynog-IP13667-Ag-1/ GM-Tg-cynog-IP13667-Ag-2;
GM-Tg-felg-IP13667-Ag-1/ GM-Tg-felg-IP13667-Ag-2; GM-Tg-cang-IP13667-Ag-1/ GM-Tg-cang-IP13667-Ag-2;
GM-Tg-bovg-IP13667-Ag-1/ GM-Tg-bovg-IP13667-Ag-2; GM-Tg-equg-IP13667-Ag-1/ GM-Tg-equg-IP13667-Ag-2
Products Name NAPRT1/NAPRT protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NAPRT1/NAPRT
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NAPRT1/NAPRT protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.